Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Health

Brazil company requests emergency use approval for Russian vaccine

FILE PHOTO: A medical worker fills a syringe with Sputnik V (Gam-COVID-Vac) vaccine as she prepares to vaccinate a Russian Army service member at a clinic in the city of Rostov-On-Don, Russia December 22, 2020. REUTERS/Sergey Pivovarov/File Photo

Brazilian pharmaceutical company União Química said on Friday that, together with the Russian Direct Investment Fund (RDIF), it has requested regulatory approval for emergency use of Russia's COVID-19 vaccine Sputnik V.

The request, filed with Brazilian health regulator Anvisa, seeks approval for the use of 10 million doses of Sputnik V in Brazil in the first quarter of 2021, the company said in a statement issued in Moscow. Anvisa officials said the Russian vaccine would have to be submitted to Phase III clinical trials in Brazil before its use can be authorized.

(Reporting by Anthony Boadle; Editing by Leslie Adler)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.